Quarterly report pursuant to Section 13 or 15(d)

Shareholders Equity (Details 1)

v3.20.2
Shareholders Equity (Details 1)
$ / shares in Units, $ in Thousands
9 Months Ended
Sep. 30, 2020
USD ($)
$ / shares
shares
Number of Options  
Outstanding, beginning balance 3,143,802
Granted 893,700
Forfeited (61,110)
Exercised (304,843)
Outstanding, ending balance 3,671,549
Vested at end of period 1,738,957
Weighted average remaining contractual life - years 7 years 9 months 25 days
Weighted average exercise price  
Outstanding, beginning balance | $ / shares $ 1.09
Granted | $ / shares 6.16
Forfeited | $ / shares 3.47
Exercised | $ / shares 0.70
Outstanding, ending balance | $ / shares $ 3.08
Aggregate intrinsic value  
Outstanding, beginning balance | $ $ 25,733
Outstanding, ending balance | $ $ 12,665